JavaScript NENÍ povolen !

Prosím povolte JavaScript.

* Zobrazit nápovědu

MeSH: forkhead box protein M1

1 záznamů v Medvik Filtry

Článek online

Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance

Khan, I
Autor Khan, I ORCID University of Illinois at Chicago, Department of Medicine, Chicago, IL, USA Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA
Kaempf, A
Autor Kaempf, A OHSU Knight Cancer Institute, School of Medicine, Portland, OR, USA
Raghuwanshi, S
Autor Raghuwanshi, S ORCID University of Illinois at Chicago, Department of Medicine, Chicago, IL, USA
Chesnokov, M
Autor Chesnokov, M ORCID Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
Zhang, X
Autor Zhang, X University of Illinois at Chicago, Department of Medicine, Chicago, IL, USA
Wang, Z
Autor Wang, Z The Czech Advanced Technology and Research Institute (CATRIN) of Palacký University, Olomouc, Czech Republic University of Groningen, Groningen, Netherlands
Domling, A
Autor Domling, A The Czech Advanced Technology and Research Institute (CATRIN) of Palacký University, Olomouc, Czech Republic
Tyner, J W
Autor Tyner, J W ORCID OHSU Knight Cancer Institute, School of Medicine, Portland, OR, USA
Camacho, C
Autor Camacho, C Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA, USA
Gartel, A L
Autor Gartel, A L ORCID University of Illinois at Chicago, Department of Medicine, Chicago, IL, USA. agartel@uic.edu

Blood cancer journal. 2023 ; 13 (1) : 128. [pub] 20230822

Blood Cancer J
ISSN 2044-5385
Medvik
Zdroj

MeSH
akutní myeloidní leukemie * farmakoterapie genetika MeSH
chemorezistence * genetika MeSH
forkhead box protein M1 genetika MeSH
jaderné proteiny genetika MeSH
lidé MeSH
Check Tag
lidé MeSH
Publikační typ
dopisy MeSH
práce podpořená grantem MeSH
Research Support, N.I.H., Extramural MeSH